发明公开
EP2142538A1 DERIVATIVES AND ANALOGS OF CHROMAN AS FUNCTIONALLY SELECTIVE ALPHA2C ADRENORECEPTOR AGONISTS
有权
衍生物和模拟色功能性选择性阻断alpha2C激动剂
- 专利标题： DERIVATIVES AND ANALOGS OF CHROMAN AS FUNCTIONALLY SELECTIVE ALPHA2C ADRENORECEPTOR AGONISTS
- 专利标题（中）： 衍生物和模拟色功能性选择性阻断alpha2C激动剂
-
申请号： EP08714240.2申请日： 2008-02-11
-
公开(公告)号： EP2142538A1公开(公告)日： 2010-01-13
- 发明人: ZHENG, Junying , MCCORMICK, Kevin, D. , CHAO, Jianhua , BOYCE, Christopher, W. , ASLANIAN, Robert, G. , YU, Younong
- 申请人： Schering Corporation
- 申请人地址： 2000 Galloping Hill Road Kenilworth, NJ 07033-0530 US
- 专利权人： Schering Corporation
- 当前专利权人： Schering Corporation
- 当前专利权人地址： 2000 Galloping Hill Road Kenilworth, NJ 07033-0530 US
- 代理机构： HOFFMANN EITLE
- 优先权： US901071P 20070213; US972892P 20070917
- 国际公布： WO2008100459 20080821
- 主分类号： C07D405/06
- IPC分类号： C07D405/06 ; C07D405/08 ; C07D405/14 ; C07D409/06 ; C07D417/14 ; C07D491/052 ; A61K31/353 ; A61P25/06
摘要：
In its many embodiments, the present invention provides a novel class of chroman compounds of formula I as α2C adrenergic receptor agonists, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of prepaxing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more conditions associated with the α2C adrenergic receptors using such compounds or pharmaceutical compositions.
公开/授权文献
信息查询
